CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer
Sign Up to like & getrecommendations! Published in 2017 at "Oncogene"
DOI: 10.1038/onc.2017.87
Abstract: CRIPTO (CR-1, TDGF1) is a cell surface/secreted oncoprotein actively involved in development and cancer. Here, we report that high expression of CRIPTO correlates with poor survival in stratified risk groups of prostate cancer (PCa) patients.… read more here.
Keywords: cripto signaling; cripto grp78; prostate cancer; cripto ... See more keywords